<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/cgt/journal/vaop/ncurrent/rss.rdf">
<title>Cancer Gene Therapy</title>
<description/>
<link>http://www.nature.com/cgt/journal/vaop/ncurrent/rss.rdf</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>
Copyright &#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:issn>0929-1903</prism:issn>
<prism:copyright>
Copyright &#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/cgt.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.18"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.23"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.24"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.25"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.27"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.28"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.30"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.31"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.32"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.33"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.34"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.35"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.36"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.38"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.39"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.40"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.41"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.42"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.43"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.44"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.45"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.47"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.48"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.49"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.51"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.52"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.53"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.54"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.55"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.57"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/cgt.2008.58"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/cgt.gif">
<title>Cancer Gene Therapy</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/cgt.gif</url>
<link>http://www.nature.com/cgt/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.18">
<title>Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2&#47;neu stimulates efficient HER-2&#47;neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice</title>
<link>http://dx.doi.org/10.1038/cgt.2008.18</link>
<content:encoded><![CDATA[

<p>
<b>Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2&#47;neu stimulates efficient HER-2&#47;neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice</b>
</p>
<p>Cancer Gene Therapy advance online publication, April 18, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.18">doi:10.1038/cgt.2008.18</a>
</p>
<p>Authors: S Sas, T Chan, A Sami, A El-Gayed
&amp; J Xiang</p>
]]></content:encoded>
<dc:title>Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2&#47;neu stimulates efficient HER-2&#47;neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice</dc:title>
<dc:creator>S Sas</dc:creator>
<dc:creator>T Chan</dc:creator>
<dc:creator>A Sami</dc:creator>
<dc:creator>A El-Gayed</dc:creator>
<dc:creator>J Xiang</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.18</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, April 18, 2008</dc:source>
<dc:date>April 18, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>April 18, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.23">
<title>Primary neural stem&#47;progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma</title>
<link>http://dx.doi.org/10.1038/cgt.2008.23</link>
<content:encoded><![CDATA[

<p>
<b>Primary neural stem&#47;progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma</b>
</p>
<p>Cancer Gene Therapy advance online publication, April 18, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.23">doi:10.1038/cgt.2008.23</a>
</p>
<p>Authors: A Lorico, J Mercapide, V Soloduschko, M Alexeyev, O Fodstad
&amp; G Rappa</p>
]]></content:encoded>
<dc:title>Primary neural stem&#47;progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma</dc:title>
<dc:creator>A Lorico</dc:creator>
<dc:creator>J Mercapide</dc:creator>
<dc:creator>V Soloduschko</dc:creator>
<dc:creator>M Alexeyev</dc:creator>
<dc:creator>O Fodstad</dc:creator>
<dc:creator>G Rappa</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.23</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, April 18, 2008</dc:source>
<dc:date>April 18, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>April 18, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.24">
<title>A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells</title>
<link>http://dx.doi.org/10.1038/cgt.2008.24</link>
<content:encoded><![CDATA[

<p>
<b>A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells</b>
</p>
<p>Cancer Gene Therapy advance online publication, April 18, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.24">doi:10.1038/cgt.2008.24</a>
</p>
<p>Authors: T T Poulsen, N Pedersen, H Juel
&amp; H S Poulsen</p>
]]></content:encoded>
<dc:title>A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells</dc:title>
<dc:creator>T T Poulsen</dc:creator>
<dc:creator>N Pedersen</dc:creator>
<dc:creator>H Juel</dc:creator>
<dc:creator>H S Poulsen</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.24</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, April 18, 2008</dc:source>
<dc:date>April 18, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>April 18, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.25">
<title>Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis</title>
<link>http://dx.doi.org/10.1038/cgt.2008.25</link>
<content:encoded><![CDATA[

<p>
<b>Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 13, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.25">doi:10.1038/cgt.2008.25</a>
</p>
<p>Authors: R L Novak
&amp; A C Phillips</p>
]]></content:encoded>
<dc:title>Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis</dc:title>
<dc:creator>R L Novak</dc:creator>
<dc:creator>A C Phillips</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.25</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 13, 2008</dc:source>
<dc:date>June 13, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 13, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.27">
<title>HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells</title>
<link>http://dx.doi.org/10.1038/cgt.2008.27</link>
<content:encoded><![CDATA[

<p>
<b>HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.27">doi:10.1038/cgt.2008.27</a>
</p>
<p>Authors: I A W Ho, K Y W Chan, L Miao, W S N Shim, C M Guo, P Cheang, K M Hui
&amp; P Y P Lam</p>
]]></content:encoded>
<dc:title>HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells</dc:title>
<dc:creator>I A W Ho</dc:creator>
<dc:creator>K Y W Chan</dc:creator>
<dc:creator>L Miao</dc:creator>
<dc:creator>W S N Shim</dc:creator>
<dc:creator>C M Guo</dc:creator>
<dc:creator>P Cheang</dc:creator>
<dc:creator>K M Hui</dc:creator>
<dc:creator>P Y P Lam</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.27</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.28">
<title>A dual role of p21waf1&#47;cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate</title>
<link>http://dx.doi.org/10.1038/cgt.2008.28</link>
<content:encoded><![CDATA[

<p>
<b>A dual role of p21waf1&#47;cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate</b>
</p>
<p>Cancer Gene Therapy advance online publication, May 16, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.28">doi:10.1038/cgt.2008.28</a>
</p>
<p>Authors: S Kraljevic Pavelic, T Cacev
&amp; M Kralj</p>
]]></content:encoded>
<dc:title>A dual role of p21waf1&#47;cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate</dc:title>
<dc:creator>S Kraljevic Pavelic</dc:creator>
<dc:creator>T Cacev</dc:creator>
<dc:creator>M Kralj</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.28</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, May 16, 2008</dc:source>
<dc:date>May 16, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>May 16, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.30">
<title>Chimeric adenoviral vector Ad5&#47;F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo</title>
<link>http://dx.doi.org/10.1038/cgt.2008.30</link>
<content:encoded><![CDATA[

<p>
<b>Chimeric adenoviral vector Ad5&#47;F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.30">doi:10.1038/cgt.2008.30</a>
</p>
<p>Authors: D-B Xiang, Z-T Chen, D Wang, M-X Li, J-Y Xie, Y-S Zhang, Y Qing, Z-P Li
&amp; J Xie</p>
]]></content:encoded>
<dc:title>Chimeric adenoviral vector Ad5&#47;F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo</dc:title>
<dc:creator>D-B Xiang</dc:creator>
<dc:creator>Z-T Chen</dc:creator>
<dc:creator>D Wang</dc:creator>
<dc:creator>M-X Li</dc:creator>
<dc:creator>J-Y Xie</dc:creator>
<dc:creator>Y-S Zhang</dc:creator>
<dc:creator>Y Qing</dc:creator>
<dc:creator>Z-P Li</dc:creator>
<dc:creator>J Xie</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.30</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.31">
<title>Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors</title>
<link>http://dx.doi.org/10.1038/cgt.2008.31</link>
<content:encoded><![CDATA[

<p>
<b>Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.31">doi:10.1038/cgt.2008.31</a>
</p>
<p>Authors: B Yaacov, E Elihaoo, I lazar, M Ben-Shlomo, I Greenbaum, A Panet
&amp; Z Zakay-Rones</p>
]]></content:encoded>
<dc:title>Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors</dc:title>
<dc:creator>B Yaacov</dc:creator>
<dc:creator>E Elihaoo</dc:creator>
<dc:creator>I lazar</dc:creator>
<dc:creator>M Ben-Shlomo</dc:creator>
<dc:creator>I Greenbaum</dc:creator>
<dc:creator>A Panet</dc:creator>
<dc:creator>Z Zakay-Rones</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.31</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.32">
<title>JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase</title>
<link>http://dx.doi.org/10.1038/cgt.2008.32</link>
<content:encoded><![CDATA[

<p>
<b>JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.32">doi:10.1038/cgt.2008.32</a>
</p>
<p>Authors: W Hu, W Hofstetter, W Guo, H Li, A Pataer, H H Peng, Z S Guo, D L Bartlett, A Lin, S G Swisher
&amp; B Fang</p>
]]></content:encoded>
<dc:title>JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase</dc:title>
<dc:creator>W Hu</dc:creator>
<dc:creator>W Hofstetter</dc:creator>
<dc:creator>W Guo</dc:creator>
<dc:creator>H Li</dc:creator>
<dc:creator>A Pataer</dc:creator>
<dc:creator>H H Peng</dc:creator>
<dc:creator>Z S Guo</dc:creator>
<dc:creator>D L Bartlett</dc:creator>
<dc:creator>A Lin</dc:creator>
<dc:creator>S G Swisher</dc:creator>
<dc:creator>B Fang</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.32</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.33">
<title>Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy</title>
<link>http://dx.doi.org/10.1038/cgt.2008.33</link>
<content:encoded><![CDATA[

<p>
<b>Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.33">doi:10.1038/cgt.2008.33</a>
</p>
<p>Authors: Y Gao, S S M Ng, D H W Chau, H Yao, C Yang, K Man, P T Huang, C Huang, J J Huang, H-F Kung
&amp; M C Lin</p>
]]></content:encoded>
<dc:title>Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy</dc:title>
<dc:creator>Y Gao</dc:creator>
<dc:creator>S S M Ng</dc:creator>
<dc:creator>D H W Chau</dc:creator>
<dc:creator>H Yao</dc:creator>
<dc:creator>C Yang</dc:creator>
<dc:creator>K Man</dc:creator>
<dc:creator>P T Huang</dc:creator>
<dc:creator>C Huang</dc:creator>
<dc:creator>J J Huang</dc:creator>
<dc:creator>H-F Kung</dc:creator>
<dc:creator>M C Lin</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.33</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.34">
<title>Dual induction of PKR with E2F-1 and IFN-&#945; to enhance gene therapy against hepatocellular carcinoma</title>
<link>http://dx.doi.org/10.1038/cgt.2008.34</link>
<content:encoded><![CDATA[

<p>
<b>Dual induction of PKR with E2F-1 and IFN-&#945; to enhance gene therapy against hepatocellular carcinoma</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.34">doi:10.1038/cgt.2008.34</a>
</p>
<p>Authors: V Roh, A Laemmle, U Von Holzen, D Stroka, J-F Dufour, K K Hunt, D Candinas
&amp; S A Vorburger</p>
]]></content:encoded>
<dc:title>Dual induction of PKR with E2F-1 and IFN-&#945; to enhance gene therapy against hepatocellular carcinoma</dc:title>
<dc:creator>V Roh</dc:creator>
<dc:creator>A Laemmle</dc:creator>
<dc:creator>U Von Holzen</dc:creator>
<dc:creator>D Stroka</dc:creator>
<dc:creator>J-F Dufour</dc:creator>
<dc:creator>K K Hunt</dc:creator>
<dc:creator>D Candinas</dc:creator>
<dc:creator>S A Vorburger</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.34</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.35">
<title>Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck</title>
<link>http://dx.doi.org/10.1038/cgt.2008.35</link>
<content:encoded><![CDATA[

<p>
<b>Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.35">doi:10.1038/cgt.2008.35</a>
</p>
<p>Authors: P Michaluart, K A Abdallah, F D Lima, R Smith, R A Moys&#233;s, V Coelho, G D Victora, A Socorro-Silva, E C Volsi, C R Z&#225;rate-Blad&#233;s, A R Ferraz, A K Barreto, M C Chammas, R Gomes, E Gebrim, L Arakawa-Sugueno, K P Fernandes, P A Lotufo, M R Cardoso, J Kalil
&amp; C L Silva</p>
]]></content:encoded>
<dc:title>Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck</dc:title>
<dc:creator>P Michaluart</dc:creator>
<dc:creator>K A Abdallah</dc:creator>
<dc:creator>F D Lima</dc:creator>
<dc:creator>R Smith</dc:creator>
<dc:creator>R A Moys&#233;s</dc:creator>
<dc:creator>V Coelho</dc:creator>
<dc:creator>G D Victora</dc:creator>
<dc:creator>A Socorro-Silva</dc:creator>
<dc:creator>E C Volsi</dc:creator>
<dc:creator>C R Z&#225;rate-Blad&#233;s</dc:creator>
<dc:creator>A R Ferraz</dc:creator>
<dc:creator>A K Barreto</dc:creator>
<dc:creator>M C Chammas</dc:creator>
<dc:creator>R Gomes</dc:creator>
<dc:creator>E Gebrim</dc:creator>
<dc:creator>L Arakawa-Sugueno</dc:creator>
<dc:creator>K P Fernandes</dc:creator>
<dc:creator>P A Lotufo</dc:creator>
<dc:creator>M R Cardoso</dc:creator>
<dc:creator>J Kalil</dc:creator>
<dc:creator>C L Silva</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.35</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.36">
<title>Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model</title>
<link>http://dx.doi.org/10.1038/cgt.2008.36</link>
<content:encoded><![CDATA[

<p>
<b>Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 6, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.36">doi:10.1038/cgt.2008.36</a>
</p>
<p>Authors: F Solly, R Fish, B Simard, N Bolle, E Kruithof, B Polack
&amp; G Pernod</p>
]]></content:encoded>
<dc:title>Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model</dc:title>
<dc:creator>F Solly</dc:creator>
<dc:creator>R Fish</dc:creator>
<dc:creator>B Simard</dc:creator>
<dc:creator>N Bolle</dc:creator>
<dc:creator>E Kruithof</dc:creator>
<dc:creator>B Polack</dc:creator>
<dc:creator>G Pernod</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.36</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 6, 2008</dc:source>
<dc:date>June 6, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 6, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.38">
<title>Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells</title>
<link>http://dx.doi.org/10.1038/cgt.2008.38</link>
<content:encoded><![CDATA[

<p>
<b>Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 20, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.38">doi:10.1038/cgt.2008.38</a>
</p>
<p>Authors: W Song, Z Dong, T Jin, M G Mantellini, G N&#250;&#241;ez
&amp; J E N&#246;r</p>
]]></content:encoded>
<dc:title>Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells</dc:title>
<dc:creator>W Song</dc:creator>
<dc:creator>Z Dong</dc:creator>
<dc:creator>T Jin</dc:creator>
<dc:creator>M G Mantellini</dc:creator>
<dc:creator>G N&#250;&#241;ez</dc:creator>
<dc:creator>J E N&#246;r</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.38</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 20, 2008</dc:source>
<dc:date>June 20, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 20, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.39">
<title>Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model</title>
<link>http://dx.doi.org/10.1038/cgt.2008.39</link>
<content:encoded><![CDATA[

<p>
<b>Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 13, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.39">doi:10.1038/cgt.2008.39</a>
</p>
<p>Authors: P T Winnard, M Botlagunta, J B Kluth, S Mukadam, B Krishnamachary, F Vesuna
&amp; V Raman</p>
]]></content:encoded>
<dc:title>Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model</dc:title>
<dc:creator>P T Winnard</dc:creator>
<dc:creator>M Botlagunta</dc:creator>
<dc:creator>J B Kluth</dc:creator>
<dc:creator>S Mukadam</dc:creator>
<dc:creator>B Krishnamachary</dc:creator>
<dc:creator>F Vesuna</dc:creator>
<dc:creator>V Raman</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.39</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 13, 2008</dc:source>
<dc:date>June 13, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 13, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.40">
<title>Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication</title>
<link>http://dx.doi.org/10.1038/cgt.2008.40</link>
<content:encoded><![CDATA[

<p>
<b>Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 13, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.40">doi:10.1038/cgt.2008.40</a>
</p>
<p>Authors: Y Y Mahller, B Sakthivel, W H Baird, B J Aronow, Y-H Hsu, T P Cripe
&amp; R Mehrian-Shai</p>
]]></content:encoded>
<dc:title>Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication</dc:title>
<dc:creator>Y Y Mahller</dc:creator>
<dc:creator>B Sakthivel</dc:creator>
<dc:creator>W H Baird</dc:creator>
<dc:creator>B J Aronow</dc:creator>
<dc:creator>Y-H Hsu</dc:creator>
<dc:creator>T P Cripe</dc:creator>
<dc:creator>R Mehrian-Shai</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.40</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 13, 2008</dc:source>
<dc:date>June 13, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 13, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.41">
<title>Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects</title>
<link>http://dx.doi.org/10.1038/cgt.2008.41</link>
<content:encoded><![CDATA[

<p>
<b>Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 4, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.41">doi:10.1038/cgt.2008.41</a>
</p>
<p>Authors: H-T Jin, J-I Youn, S-Y Choi, S-H Seo, S-H Park, M-Y Song, S-H Yang
&amp; Y-C Sung</p>
]]></content:encoded>
<dc:title>Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects</dc:title>
<dc:creator>H-T Jin</dc:creator>
<dc:creator>J-I Youn</dc:creator>
<dc:creator>S-Y Choi</dc:creator>
<dc:creator>S-H Seo</dc:creator>
<dc:creator>S-H Park</dc:creator>
<dc:creator>M-Y Song</dc:creator>
<dc:creator>S-H Yang</dc:creator>
<dc:creator>Y-C Sung</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.41</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 4, 2008</dc:source>
<dc:date>July 4, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 4, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.42">
<title>Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth</title>
<link>http://dx.doi.org/10.1038/cgt.2008.42</link>
<content:encoded><![CDATA[

<p>
<b>Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 11, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.42">doi:10.1038/cgt.2008.42</a>
</p>
<p>Authors: G Jeudy, F Salvadori, B Chauffert, E Solary, P Vabres
&amp; J Chluba</p>
]]></content:encoded>
<dc:title>Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth</dc:title>
<dc:creator>G Jeudy</dc:creator>
<dc:creator>F Salvadori</dc:creator>
<dc:creator>B Chauffert</dc:creator>
<dc:creator>E Solary</dc:creator>
<dc:creator>P Vabres</dc:creator>
<dc:creator>J Chluba</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.42</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 11, 2008</dc:source>
<dc:date>July 11, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 11, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.43">
<title>Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model</title>
<link>http://dx.doi.org/10.1038/cgt.2008.43</link>
<content:encoded><![CDATA[

<p>
<b>Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.43">doi:10.1038/cgt.2008.43</a>
</p>
<p>Authors: M-A Shibata, J Morimoto, E Shibata
&amp; Y Otsuki</p>
]]></content:encoded>
<dc:title>Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model</dc:title>
<dc:creator>M-A Shibata</dc:creator>
<dc:creator>J Morimoto</dc:creator>
<dc:creator>E Shibata</dc:creator>
<dc:creator>Y Otsuki</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.43</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.44">
<title>ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice</title>
<link>http://dx.doi.org/10.1038/cgt.2008.44</link>
<content:encoded><![CDATA[

<p>
<b>ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice</b>
</p>
<p>Cancer Gene Therapy advance online publication, June 27, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.44">doi:10.1038/cgt.2008.44</a>
</p>
<p>Authors: H V Reddi, P Madde, A J Reichert-Eberhardt, E C Galanis, J A Copland, B McIver, S K G Grebe
&amp; N L Eberhardt</p>
]]></content:encoded>
<dc:title>ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice</dc:title>
<dc:creator>H V Reddi</dc:creator>
<dc:creator>P Madde</dc:creator>
<dc:creator>A J Reichert-Eberhardt</dc:creator>
<dc:creator>E C Galanis</dc:creator>
<dc:creator>J A Copland</dc:creator>
<dc:creator>B McIver</dc:creator>
<dc:creator>S K G Grebe</dc:creator>
<dc:creator>N L Eberhardt</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.44</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, June 27, 2008</dc:source>
<dc:date>June 27, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>June 27, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.45">
<title>Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD</title>
<link>http://dx.doi.org/10.1038/cgt.2008.45</link>
<content:encoded><![CDATA[

<p>
<b>Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 4, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.45">doi:10.1038/cgt.2008.45</a>
</p>
<p>Authors: J-I Youn, S-H Park, H-T Jin, C-G Lee, S-H Seo, M-Y Song, C-W Lee
&amp; Y-C Sung</p>
]]></content:encoded>
<dc:title>Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD</dc:title>
<dc:creator>J-I Youn</dc:creator>
<dc:creator>S-H Park</dc:creator>
<dc:creator>H-T Jin</dc:creator>
<dc:creator>C-G Lee</dc:creator>
<dc:creator>S-H Seo</dc:creator>
<dc:creator>M-Y Song</dc:creator>
<dc:creator>C-W Lee</dc:creator>
<dc:creator>Y-C Sung</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.45</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 4, 2008</dc:source>
<dc:date>July 4, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 4, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.47">
<title>E. coli nitroreductase&#47;CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2</title>
<link>http://dx.doi.org/10.1038/cgt.2008.47</link>
<content:encoded><![CDATA[

<p>
<b>E. coli nitroreductase&#47;CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 4, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.47">doi:10.1038/cgt.2008.47</a>
</p>
<p>Authors: D J Mitchell
&amp; R F Minchin</p>
]]></content:encoded>
<dc:title>E. coli nitroreductase&#47;CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2</dc:title>
<dc:creator>D J Mitchell</dc:creator>
<dc:creator>R F Minchin</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.47</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 4, 2008</dc:source>
<dc:date>July 4, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 4, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.48">
<title>IL-18-producing Salmonella inhibit tumor growth</title>
<link>http://dx.doi.org/10.1038/cgt.2008.48</link>
<content:encoded><![CDATA[

<p>
<b>IL-18-producing Salmonella inhibit tumor growth</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.48">doi:10.1038/cgt.2008.48</a>
</p>
<p>Authors: M Loeffler, G Le'Negrate, M Krajewska
&amp; J C Reed</p>
]]></content:encoded>
<dc:title>IL-18-producing Salmonella inhibit tumor growth</dc:title>
<dc:creator>M Loeffler</dc:creator>
<dc:creator>G Le'Negrate</dc:creator>
<dc:creator>M Krajewska</dc:creator>
<dc:creator>J C Reed</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.48</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.49">
<title>Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43</title>
<link>http://dx.doi.org/10.1038/cgt.2008.49</link>
<content:encoded><![CDATA[

<p>
<b>Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 4, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.49">doi:10.1038/cgt.2008.49</a>
</p>
<p>Authors: S Cottin, K Ghani
&amp; M Caruso</p>
]]></content:encoded>
<dc:title>Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43</dc:title>
<dc:creator>S Cottin</dc:creator>
<dc:creator>K Ghani</dc:creator>
<dc:creator>M Caruso</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.49</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 4, 2008</dc:source>
<dc:date>July 4, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 4, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.51">
<title>Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells</title>
<link>http://dx.doi.org/10.1038/cgt.2008.51</link>
<content:encoded><![CDATA[

<p>
<b>Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 11, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.51">doi:10.1038/cgt.2008.51</a>
</p>
<p>Authors: R Frade, N Rousselet
&amp; D Jean</p>
]]></content:encoded>
<dc:title>Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells</dc:title>
<dc:creator>R Frade</dc:creator>
<dc:creator>N Rousselet</dc:creator>
<dc:creator>D Jean</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.51</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 11, 2008</dc:source>
<dc:date>July 11, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 11, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.52">
<title>Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo</title>
<link>http://dx.doi.org/10.1038/cgt.2008.52</link>
<content:encoded><![CDATA[

<p>
<b>Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 11, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.52">doi:10.1038/cgt.2008.52</a>
</p>
<p>Authors: Y Gan, J Gu, X Cai, J Hu, X Y Liu
&amp; X Zhao</p>
]]></content:encoded>
<dc:title>Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo</dc:title>
<dc:creator>Y Gan</dc:creator>
<dc:creator>J Gu</dc:creator>
<dc:creator>X Cai</dc:creator>
<dc:creator>J Hu</dc:creator>
<dc:creator>X Y Liu</dc:creator>
<dc:creator>X Zhao</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.52</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 11, 2008</dc:source>
<dc:date>July 11, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 11, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.53">
<title>Conditioned medium from Ad-IFN-&#945;-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect</title>
<link>http://dx.doi.org/10.1038/cgt.2008.53</link>
<content:encoded><![CDATA[

<p>
<b>Conditioned medium from Ad-IFN-&#945;-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 11, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.53">doi:10.1038/cgt.2008.53</a>
</p>
<p>Authors: X Zhang, L Dong, E Chapman
&amp; W F Benedict</p>
]]></content:encoded>
<dc:title>Conditioned medium from Ad-IFN-&#945;-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect</dc:title>
<dc:creator>X Zhang</dc:creator>
<dc:creator>L Dong</dc:creator>
<dc:creator>E Chapman</dc:creator>
<dc:creator>W F Benedict</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.53</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 11, 2008</dc:source>
<dc:date>July 11, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 11, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.54">
<title>Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50&#8201;kb DNA fragmentation</title>
<link>http://dx.doi.org/10.1038/cgt.2008.54</link>
<content:encoded><![CDATA[

<p>
<b>Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50&#8201;kb DNA fragmentation</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.54">doi:10.1038/cgt.2008.54</a>
</p>
<p>Authors: J Zhou, X-Q Zhang, F Ashoori, D J McConkey, M A Knowles, L Dong
&amp; W F Benedict</p>
]]></content:encoded>
<dc:title>Early RB94-produced cytotoxicity in cancer cells is independent of caspase activation or 50&#8201;kb DNA fragmentation</dc:title>
<dc:creator>J Zhou</dc:creator>
<dc:creator>X-Q Zhang</dc:creator>
<dc:creator>F Ashoori</dc:creator>
<dc:creator>D J McConkey</dc:creator>
<dc:creator>M A Knowles</dc:creator>
<dc:creator>L Dong</dc:creator>
<dc:creator>W F Benedict</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.54</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.55">
<title>Recombinant vesicular stomatitis virus targeted to Her2&#47;neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors</title>
<link>http://dx.doi.org/10.1038/cgt.2008.55</link>
<content:encoded><![CDATA[

<p>
<b>Recombinant vesicular stomatitis virus targeted to Her2&#47;neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.55">doi:10.1038/cgt.2008.55</a>
</p>
<p>Authors: Y Gao, P Whitaker-Dowling, J A Griffin, M A Barmada
&amp; I Bergman</p>
]]></content:encoded>
<dc:title>Recombinant vesicular stomatitis virus targeted to Her2&#47;neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors</dc:title>
<dc:creator>Y Gao</dc:creator>
<dc:creator>P Whitaker-Dowling</dc:creator>
<dc:creator>J A Griffin</dc:creator>
<dc:creator>M A Barmada</dc:creator>
<dc:creator>I Bergman</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.55</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.57">
<title>Chimeric form of tumor necrosis factor-&#945; has enhanced surface expression and antitumor activity</title>
<link>http://dx.doi.org/10.1038/cgt.2008.57</link>
<content:encoded><![CDATA[

<p>
<b>Chimeric form of tumor necrosis factor-&#945; has enhanced surface expression and antitumor activity</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.57">doi:10.1038/cgt.2008.57</a>
</p>
<p>Authors: R Rieger, D Whitacre, M J Cantwell, C Prussak
&amp; T J Kipps</p>
]]></content:encoded>
<dc:title>Chimeric form of tumor necrosis factor-&#945; has enhanced surface expression and antitumor activity</dc:title>
<dc:creator>R Rieger</dc:creator>
<dc:creator>D Whitacre</dc:creator>
<dc:creator>M J Cantwell</dc:creator>
<dc:creator>C Prussak</dc:creator>
<dc:creator>T J Kipps</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.57</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
<item rdf:about="http://dx.doi.org/10.1038/cgt.2008.58">
<title>REIC&#47;Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7&#47;ADR cells and induces apoptosis in breast cancer</title>
<link>http://dx.doi.org/10.1038/cgt.2008.58</link>
<content:encoded><![CDATA[

<p>
<b>REIC&#47;Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7&#47;ADR cells and induces apoptosis in breast cancer</b>
</p>
<p>Cancer Gene Therapy advance online publication, July 25, 2008. <a href="http://dx.doi.org/10.1038/cgt.2008.58">doi:10.1038/cgt.2008.58</a>
</p>
<p>Authors: K Kawasaki, M Watanabe, M Sakaguchi, Y Ogasawara, K Ochiai, Y Nasu, H Doihara, Y Kashiwakura, N-h Huh, H Kumon
&amp; H Date</p>
]]></content:encoded>
<dc:title>REIC&#47;Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7&#47;ADR cells and induces apoptosis in breast cancer</dc:title>
<dc:creator>K Kawasaki</dc:creator>
<dc:creator>M Watanabe</dc:creator>
<dc:creator>M Sakaguchi</dc:creator>
<dc:creator>Y Ogasawara</dc:creator>
<dc:creator>K Ochiai</dc:creator>
<dc:creator>Y Nasu</dc:creator>
<dc:creator>H Doihara</dc:creator>
<dc:creator>Y Kashiwakura</dc:creator>
<dc:creator>N-h Huh</dc:creator>
<dc:creator>H Kumon</dc:creator>
<dc:creator>H Date</dc:creator>
<dc:identifier>doi:10.1038/cgt.2008.58</dc:identifier>
<dc:source>Cancer Gene Therapy advance online publication, July 25, 2008</dc:source>
<dc:date>July 25, 2008</dc:date>
<prism:publicationName>Cancer Gene Therapy</prism:publicationName>
<prism:publicationDate>July 25, 2008</prism:publicationDate>
<prism:volume>aop</prism:volume>
<prism:number>current</prism:number>
</item>
</rdf:RDF>
